Specifically, elevated levels of NET markers, such as circulating Myeloperoxidase (MPO)-DNA complexes, have been found in the serum of patients with a histological diagnosis of MASH compared to patients with normal liver histology. The gene discussed is MPO; the disease is metabolic dysfunction-associated steatohepatitis.